Unser Experte für Gebärmutterhalskrebs

Prof. Dr. med. Sara Yvonne Brucker

Spezialisierungen: Gebärmutterkrebs, Brustkrebs, Jugendgynäkologie, Korrektur gynäkologischer Fehlbildungen

Institution and position:  Medical Director of the Research Institute for Women’s Health at the University Hospital Tübingen and Stellv. Director of the Department of Women’s Health at the University Hospital Ulm. Chairholder (W3) for Special Gynecology and Women’s Health at the Eberhard-Karls-University Tübingen.

As of: 14.03.2018

Die Mitschrift des Interviews mit Prof. Dr. med. Sara Yvonne Brucker zum Thema “Gebärmutterhalskrebs”

Wie gefährlich ist der Gebärmutterkrebs?

Cervical cancer is not the same as uterine cancer and that is very important. You have to tell if the cancer is in the uterine cavity, for example, or if it is sitting on the cervix. Generally, regardless of localization, uterine cancer is a cancer that is often detected very early, and therefore the chances of recovery are very, very high. We can usually cure such patients with a single therapy.

Gibt es Risikofaktoren für den Gebärmutterkrebs? Die Antibabypille?

There are risk factors for uterine cancer and again there is the distinction: is it a Krens of the cervix or the uterine cavity. It is now known that cervix cancer is mainly caused by viruses called human papillomaviruses. These are viruses that are transmitted mainly during intercourse, but just now there is a vaccine, a proper prevention against cancer. Looking at the uterine cancer, the contraceptive pill in the sense does not have the effect as a risk factor. However, one has to keep in mind that in summary, if a patient is overweight, for example, or if she has diabetes or hypertension, then she is more likely to be one of the women,

Besteht nach den Wechseljahren ein besonderes Krebsrisiko?

Generell gilt, dass beim Gebärmutterkrebs, egal ob Gebärmutterhöhlenkrebs oder Gebärmutterhalskrebs, die Wechseljahre eher zur Frühentdeckung beitragen. Der Vorteil der Wechseljahre, und in dem Fall kann man tatsächlich von Vorteil bei den Wechseljahren sprechen, ist, dass wenn in den Wechseljahren eine Blutung auftritt, die dann eben als postmenopausale Blutung bezeichnet wird, dass das ein sehr frühes Zeichen für eine mögliche Gebärmutterkörperkrebs-Erkrankung ist. Das heißt, Gebärmutterkrebs der in den Wechseljahren oder danach auftritt, ist ein Krebs der in einem ganz, ganz frühen Stadium erkannt wird, eben durch dieses erste Zeichen der sogenannten PMB, das heißt einer postmenopausalen Blutung.

Please subscribe to get access to rest of the questions. Click here

Was kann ich selber tun, um das Krebsrisiko zu senken?

. . . .

Wann kommen weitere bildgebende Verfahren in Frage?

Infos zur Person

For many years I have been involved in the field of gynecooncology, that is the cancer of the woman, especially cancer in the genital area, ie in the uterus. I’ve been on the board for more than 10 years, or I’ve been a member of several working groups on cervical cancer and treatment, as well as research into causes of cervical cancer. Something that is very important to me and what is close to my heart is also the prevention of cancer and especially in the case of cervical cancer. The early detection of cancer and there we engage, especially from the Research Institute for Women’s Health, extremely what the awareness of what education is both in the lay area but also in the field of experts and have triggered many innovations,

Infos zur Klinik

As a certified, university cancer center, especially a gynecologic cancer center, we have the full range of new innovative therapies available through the standard, standard procedures available at our clinic. In particular, but also new possibilities for therapy, especially in the so-called keyhole surgery or in the conservation of lymphatic channels, in the conservation of the removal of organs. In some cases, we can also provide organ preservation for cancer, in particular with our interdisciplinary partners, for example in radiotherapy or imaging, radiology. We offer a broad spectrum, especially in networking with our established colleagues,


Professional background

02/2014 Medical Director Research Institute for Women’s Health Deputy Managing Medical Director Department
of Women’s Health, University of Tübingen
08/2013 Reputation: Chair and Professorship University Gynecological Clinic Würzburg Julius-Maximilians-Universität Würzburg
12/2011 W3-Professorship for Specialist Gynecology and Women’s Health University Gynecological Clinic Tübingen
03/2011 Reputation: Chair and Professorship University Gynecological Clinic Salzburg Paracelsus Medical Private University
12/2010 Head of the Center for Rare Genital Malformations (ZSGF) in the Center for Rare Diseases (ZSE) Speaker of
the ZSE: Prof. Dr. med. O. Riess, Director of the Department of Med. Genetics
12/2009 Habilitation und Venia Legendi für das Fach Frauenheilkunde und Geburtshilfe
Eberhard-Karls-Universität, Tübingen
Titel: „Die Vaginalaplasie: Aktuelle Diagnose- und Therapiekonzepte“
01/2008 Geschäftsführende Oberärztin der Universitäts-Frauenklinik Tübingen
Ärztlicher Direktor: Prof. Dr. med. D. Wallwiener
01/2006 Oberärztin und Leitung des Instituts für Frauengesundheit
an der Universitäts-Frauenklinik, Eberhard-Karls-Universität Tübingen
Ärztlicher Direktor: Prof. Dr. med. D. Wallwiener
09/2005 Anerkennung als Fachärztin für Frauenheilkunde und Geburtshilfe
12/01 – 12/05 Assistenzärztin
Universitäts-Frauenklinik, Eberhard-Karls-Universität Tübingen
Ärztlicher Direktor: Prof. Dr. med. D. Wallwiener
12/2001 Approbation
06/00 – 11/01 Ärztin im Praktikum Universitäts-Frauenklinik,
Eberhard-Karls-Universität Tübingen Ärztlicher Direktor: Prof. Dr. med. D.
10/93 – 05/00 Studium der Humanmedizin an der
Albert-Ludwigs-Universität, Freiburg i. Br.
03/98 – 07/98 Studium der Humanmedizin an der Université Pierre et
Marie Curie, Paris
05/2000 Promotion an der Albert-Ludwigs-Universität Freiburg
im Breisgau
Abteilung für Neurologie, Prof. Dr. C.H. Lücking Titel:
„Präattentive visuelle Informationsverarbeitung bei Patienten mit Morbus
Parkinson“ Note: magna cum laude


2003 Forschungspreis der AGE für junge Wissenschaftler
2008 Innovationspreis der DGGG


2000 – jetzt – Hauptvorlesung Gynäkologie und Geburtshilfe
– Blockpraktikum der Frauenheilkunde und Geburtshilfe
– Vertiefungsseminare in Kleingruppen im Bereich spezielle Gynäkologie und
2005 – jetzt – Interdisziplinäre Fallkonferenzen Jugendgynäkologie
– „Teaching, training and testing“-Kurse der EAGS in MIC
– „Teaching-Live-Surgeries“ für ESHRE, AAGL, ESGE, DGGG


Member of the Board of the German Senate Society
Member of the St. Gallen Panel
Board of Directors of the European Society for Gynecological Endoscopy (ESGE)
Member of the Board AG Endoscopy (AGE)
Member AG Gynecologic Oncology (AGO), Commission „Uterus“
Member of the Board DGGG as President of the Congress 2016
Member of the Certification Commission for Breast Cancer Centers , German Cancer Society (DKG)
Member of the S3 Guideline
Group „Breast Cancer“ Founding member ISUTx (International Society of Uterine Transplantation)


  • S. Brucker, U. Krainick, M. Bamberg, B. Aydeniz, R. Kreienberg, D.
    Wallwiener Breast Centers – Rational, Functional Concept, Definition
    and Certification Gynecologist 2003; 36: 862-877
  • S. Brucker, W. Zubke, D. Wallwiener, B. Aydeniz Optimization of the
    Laparoscopic Assisted Neovagina System with New
    Application Instruments Including a New Mechanical Tension Device
    Geburtsh Frauenheilk 2004; 64: 70-75
  • Brucker S, Aydeniz B, Gegusch M, Wallwiener D, Zubke W Improvement of
    endoscopically assisted neovagina: new application
    instruments and
    traction device Gynecol Surg 2004; 1: 133-138
  • S. Brucker, U. Krainick-Strobel, R. Kreienberg, M. Bamberg, D.
    Wallwiener Breast Centers – Development in Germany Oncologist 2005;
    11: 285-297
  • W. Zubke, J. Baltzer, D. Wallwiener, S. Brucker Supracervical
    Hysterectomy by Laparoscopy in Comparison to Total Hysterectomy
    Geburtsh Frauenheilk 2005; 65: 102-109
  • U. Krainick-Strobel, H. Abele, H. Kusicka, D. Wallwiener, S. Brucker
    Recertification and Breast Centers – Effort, Quality, Opportunities
    Geburtsh Frauenheilk 2006; 66: 696-699
  • K. Rall, U. Krainick-Strobel, B. Böer, T. Iftner, S. Brucker
    Enlightenment and Prevention in Youth Gynecology – A Task for the
    Gynecologist Obstetrics Frauenheilk 2006; 66: 500-505
  • S. Brucker, M. Halber, C. Belka, T. Wolff, D. Wallwiener The
    electronic breast cancer file: Quality assurance without bureaucracy
    Geburtsh Frauenheilk 2007; 67: 884-888
  • Brucker S, Solomayer E, Zubke W, Sawalhe S, Wattiez A, Wallwiener D
    newly developed morcellator creates a new dimension in minimally invasive
    surgery J Minim Invas Gyn 2007; 14 (2): 233-9
  • IV Gruber, EH Schmidt, RL De Wilde, D. Wallwiener, S. Brucker
    Aspects of quality assurance in gynecological endoscopy Geburtsh
    Frauenheilk 2007; 67: 352-358


Further publications